🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cushing disease remains a challenging endocrine disorder in which persisten...
Status
Enrolling By Invitation
Location
Faiha Specialized Diabetes, Endocrine, and Metabolism Center
Start Date
2026-05-11
Trial ID
NCT07603466
Treatments Being Tested
This exploratory study is a proof of concept study to determine whether LCI...
Status
Completed
Location
Northwestern University Endo, Metabolism and Molecular
Start Date
2011-03-23
Trial ID
NCT01331239
Treatments Being Tested
The purpose of this study was to confirm efficacy and safety of osilodrosta...
Status
Completed
Location
University of Colorado Endocrinology Clinical Trials Unit
Start Date
2016-10-03
Trial ID
NCT02697734
Treatments Being Tested
This study assessed the blood pressure effect, safety and tolerability of L...
Status
Completed
Location
Horizon Research Group, Inc
Start Date
2008-12-22
Trial ID
NCT00817635
Treatments Being Tested
Osilodrostat has proven to be a safe and efficacious treatment for patients...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07247162
Treatments Being Tested
This study will compare the efficacy and safety of the two 11β-hydroxylase ...
Status
Recruiting
Location
Laikon General Hospital
Start Date
2025-12-01
Trial ID
NCT07268222
Treatments Being Tested
The study aimed to confirm long-term efficacy and safety of LCI699 for the ...
Status
Completed
Location
University of Colorado Hospital SC - LCI699C2301
Start Date
2014-10-06
Trial ID
NCT02180217
Treatments Being Tested
Multicenter, open-label, non-comparative study to evaluate the pharmacokine...
Status
Recruiting
Location
University of California San Francisco UCSF
Start Date
2021-04-28
Trial ID
NCT03708900
Treatments Being Tested
To characterize the pharmacokinetics of LCI699 following a single oral dose...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-11-06
Trial ID
NCT02399202
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of 1 m...
Status
Recruiting
Location
Mayo Clinic
Start Date
2026-01-14
Trial ID
NCT07104812
Treatments Being Tested